Literature DB >> 28946150

Venous and Arterial Thromboses: Two Sides of the Same Coin?

Giuseppe Lippi1, Emmanuel J Favaloro2.   

Abstract

Arterial and venous thromboses are sustained by development of intraluminal thrombi, respectively, within the venous and arterial systems. The composition and structure of arterial and venous thrombi have been historically considered as being very different. Arterial thrombi (conventionally defined as "white") have been traditionally proposed to be composed mainly of fibrin and platelet aggregates, whilst venous thrombi (conventionally defined as "red") have been proposed as mostly being enriched in fibrin and erythrocytes. This archaic dichotomy seems ever more questionable, since it barely reflects the pathophysiology of thrombus formation in vivo. Both types of thrombi are actually composed of a complex fibrin network but, importantly, also contain essentially the same blood-borne cells (i.e., red blood cells, leukocytes, and platelets), and it is only the relative content of these individual elements that differ between venous and arterial clots or, otherwise, between thrombi generated under different conditions of blood flow and shear stress. Convincing evidence now suggests that either white or red intracoronary thrombi may be present in patients with myocardial infarction and, even more importantly, red thrombi may be more prone to distal embolization during percutaneous coronary intervention than those with lower content of erythrocytes. Conversely, it is now accepted that components traditionally considered to be involved "only" in arterial thrombosis are also represented in venous thrombosis. Thus, platelets comprise important components of venous clots, although they may be present in lower amounts here than in arterial thrombi, and von Willebrand factor is also represented in both arterial and venous thrombi. Of importance, such evidence thus supports the concept that adjunctive treatment normally associated to prevention of arterial thrombosis (e.g., aspirin) may have a role also in prevention and treatment of venous thrombosis. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2017        PMID: 28946150     DOI: 10.1055/s-0037-1607202

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  14 in total

1.  Feeling the Force: Measurements of Platelet Contraction and Their Diagnostic Implications.

Authors:  Evelyn Kendall Williams; Oluwamayokun Oshinowo; Abhijit Ravindran; Wilbur A Lam; David R Myers
Journal:  Semin Thromb Hemost       Date:  2018-12-19       Impact factor: 4.180

2.  Incidence of venous thromboembolism following initiation of non-steroidal anti-inflammatory drugs in U.S. women.

Authors:  Tracy L Kinsey; Til Stürmer; Michele Jonsson Funk; Charles Poole; Ross J Simpson; Robert J Glynn
Journal:  Rheumatology (Oxford)       Date:  2020-09-01       Impact factor: 7.580

Review 3.  e-thrombosis: epidemiology, physiopathology and rationale for preventing computer-related thrombosis.

Authors:  Giuseppe Lippi; Camilla Mattiuzzi; Emmanuel J Favaloro
Journal:  Ann Transl Med       Date:  2018-09

Review 4.  Rare thrombophilic conditions.

Authors:  Gian Luca Salvagno; Chiara Pavan; Giuseppe Lippi
Journal:  Ann Transl Med       Date:  2018-09

5.  Stroke Classification: Critical Role of Unusually Large von Willebrand Factor Multimers and Tissue Factor on Clinical Phenotypes Based on Novel "Two-Path Unifying Theory" of Hemostasis.

Authors:  Jae C Chang
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

Review 6.  VWF, Platelets and the Antiphospholipid Syndrome.

Authors:  Shengshi Huang; Marisa Ninivaggi; Walid Chayoua; Bas de Laat
Journal:  Int J Mol Sci       Date:  2021-04-18       Impact factor: 5.923

7.  Complex wall modeling for hemodynamic simulations of intracranial aneurysms based on histologic images.

Authors:  Annika Niemann; Samuel Voß; Riikka Tulamo; Simon Weigand; Bernhard Preim; Philipp Berg; Sylvia Saalfeld
Journal:  Int J Comput Assist Radiol Surg       Date:  2021-03-14       Impact factor: 2.924

8.  Aspirin for thromboprophylaxis in major orthopedic surgery: old drug, new tricks?

Authors:  Giuseppeli Lippi; Gianfranco Cervellin
Journal:  Acta Biomed       Date:  2018-02-27

9.  Serum amyloid A4 is a procoagulant apolipoprotein that it is elevated in venous thrombosis patients.

Authors:  José A Fernández; Hiroshi Deguchi; Darlene J Elias; John H Griffin
Journal:  Res Pract Thromb Haemost       Date:  2019-12-29

Review 10.  Impact of Acute and Chronic Stress on Thrombosis in Healthy Individuals and Cardiovascular Disease Patients.

Authors:  Leonardo Sandrini; Alessandro Ieraci; Patrizia Amadio; Marta Zarà; Silvia Stella Barbieri
Journal:  Int J Mol Sci       Date:  2020-10-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.